News search

E.g., 27/06/2026
E.g., 27/06/2026
Rocío Sierra, Miguel Torres, Cristina Villa del Campo, Enrique Calvo, Jesús Vázquez y Consuelo Marín-Vicente.
Research
24 Jun 2026

Two CNIC teams have developed a pioneering technique to analyze proteins in individual cardiomyocytes and uncover new clues about cardiac regeneration

Florian Weinberg
About the CNIC
23 Jun 2026

CARDIOSWITCH aims to uncover how the mechanical activity of heart muscle cells shapes cardiac biology and to develop new regenerative strategies for congenital heart disease

Left: Hesham Sadek MD, PhD. Right: Ivan Menendez-Montes, PhD
Annalaura Mastrangelo
Optimal dendritic-cell-based antitumor immunotherapy with cDC1 cells requires active mitochondria. Whereas vaccination with normal cDC1 cells efficiently reduces metastasis in B16-OVA tumors, the antitumor efficacy of these cells is diminished when their mitochondria are damaged.
Research
22 May 2026

CNIC-led study identifies a mitochondrial “checkpoint” that enables dendritic cells to efficiently activate T lymphocytes against viruses and tumors

Job Verdonschot, Maastricht University Medical Center, and the Cardiovascular Research Institute Maastricht
Research
23 Apr 2026

Job Verdonschot, Maastricht University Medical Center, and the Cardiovascular Research Institute Maastricht

Michael Reth profesor de Inmunología Molecular en la Universidad de Friburgo
David Sancho, Ignacio Heras-Murillo y Stefanie Wculek.
Research
15 Apr 2026

Scientist at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and the Institute for Research in Biomedicine (IRB Barcelona) uncover a key metabolic mechanism governing immune cell readiness

El Dr. David Sancho, junto a María Cid y Lola Manterola, de la Fundación Cris contra el Cáncer
About the CNIC
13 Apr 2026

TARGET-DC, CNIC initiative led by Dr. David Sancho aims to identify novel immune checkpoints in dendritic cells to advance T-cell activation.

COMPASS
About the CNIC
31 Mar 2026

The initiative will combine innovative medical and digital technologies to improve the early detection of cardiac risk and complications in cancer patients and survivors